Insider Transactions in Q1 2022 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
10,706
-6.22%
|
$10,706
$1.87 P/Share
|
|
Mar 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
880
-12.06%
|
$880
$1.87 P/Share
|
|
Mar 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
6,946
-19.57%
|
$6,946
$1.87 P/Share
|
|
Mar 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
10,945
-5.15%
|
$10,945
$1.87 P/Share
|
|
Mar 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
10,770
-1.9%
|
$10,770
$1.87 P/Share
|
|
Mar 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
10,706
-5.81%
|
$10,706
$1.87 P/Share
|
|
Mar 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,813
+9.89%
|
-
|
|
Mar 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,050
+18.3%
|
-
|
|
Mar 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,866
+21.23%
|
-
|
|
Mar 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,938
+8.34%
|
-
|
|
Mar 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,938
+3.45%
|
-
|
|
Mar 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,813
+9.34%
|
-
|
|
Feb 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
5,436
-3.68%
|
$5,436
$1.94 P/Share
|
|
Feb 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
5,436
-4.01%
|
$5,436
$1.94 P/Share
|
|
Feb 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
81
-4.67%
|
$81
$1.94 P/Share
|
|
Feb 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
2,037
-13.76%
|
$2,037
$1.94 P/Share
|
|
Feb 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
4,442
-0.84%
|
$4,442
$1.94 P/Share
|
|
Feb 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,514
-2.57%
|
$4,514
$1.94 P/Share
|
|
Feb 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+6.49%
|
-
|
|
Feb 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+7.03%
|
-
|
|
Feb 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
182
+9.5%
|
-
|
|
Feb 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,376
+18.57%
|
-
|
|
Feb 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,375
+1.55%
|
-
|
|
Feb 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,375
+4.55%
|
-
|
|
Jan 03
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.45%
|
$14
$2.75 P/Share
|
|
Jan 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
16
+1.02%
|
-
|